Advocacy and Impact Litigation
-
Emerge Shareholder Tim Alger to Speak at 2023 INCBA Cannabis Law Institute
Emerge shareholder Tim Alger is speaking at the 2023 INCBA Cannabis Law Institute at GW Law in Washington, DC.! This…
-
Right to Try (RTT) Laws: A Battle with Multiple Fronts
By: Kathryn Tucker, JD[1] Background We have been leading efforts to open access to the investigational psychedelic drug psilocybin for…
-
Update re AIMS et al. v. DEA: DEA Doubles Down in Denying Dying Patients Access to Psilocybin
By Kathryn Tucker, JD[1] In January 2021, Dr. Sunil Aggarwal, a respected palliative care physician and founder of the Advanced…
-
At DEA’s Door: The Battle to Open Access to Psilocybin Therapy for Peace and Comfort at the End of Life
By Kathryn Tucker, JD[1] On Mother’s Day 2022, my client Erinn Baldeschwiler, a young mother of two with Stage IV…
-
The Intersection of End of Life Issues and the Oregon Psilocybin Services Act
Oregon’s Psilocybin Services Act (“PSA”) is the first state law legalizing access to psilocybin for adults. Psilocybin remains illegal to…
-
Efforts to Open Access to Psilocybin for Therapeutic Use with Those with Life Threatening Illness Continue
Emerge Law Group Special Counsel Kathryn Tucker submitted a Freedom of Information Act (“FOIA“) request to the Drug Enforcement Administration…
-
Four Organizations Dedicated to Disability and Patient Rights Join in the Fight for Terminally Ill Californians with Physical Disabilities
Our advocacy on behalf of Californians with terminal illnesses involving progressive loss of physical ability has been joined by a…
-
Fighting for Terminally Ill Californians with Physical Disabilities
Our advocacy on behalf of Californians with terminal illnesses involving progressive loss of physical ability continues. The case was filed…
-
Establishing a Pathway to Access Psilocybin for Use with Patients with Advanced Illness: UPDATE
As counsel to Dr. Sunil Aggarwal of the Advanced Integrative Medical Science (“AIMS”) Institute we have been seeking authorization for…
-
Landmark Petition to Reschedule Psilocybin filed with DEA
Bipartisan Congressional support for allowing terminal patients to seek relief from anxiety and depression in alignment with ongoing international research on…
-
Ninth Circuit ducks merits in nation’s first legal challenge to allow access to psilocybin in end-of-life care under “Right-To-Try” laws
Bipartisan Congressional support for allowing terminal patients to seek relief from anxiety and depression in alignment with ongoing international research…